rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mitchell H. Finer

Director

Company insider

Files Form 4 as: Director, PepGen; Director, Oncorus; Director and Other, Adverum Biotechnologies; Chief Scientific Officer, bluebird bio.

Every Form 4 they filed

In numbers

Trades disclosed
122
Buys
0
Sells
16
Bought
$0
Sold
$23.5M
Companies
4
Companies where not an officer
3
First trade
16 Dec 2013
Last trade
18 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
bluebird bioOfficer · last 1 Jun 20150 buys · 16 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PEPG PepGenDirector · Biotechnology · last 18 Jun 20260 buys · 0 sells
OncorusDirector · last 23 Jun 20220 buys · 0 sells
Adverum BiotechnologiesDirector, Other · last 31 Jul 20190 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Jun 2026filed 22 Jun 2026PEPG PepGenoption or derivative · BiotechnologySEC FORM 4 Code A—34,000 at $0.00filing
18 Jun 2026filed 22 Jun 2026PEPG PepGenoption or derivative · BiotechnologySEC FORM 4 Code A—34,000 at $0.00filing
27 Mar 2025filed 31 Mar 2025PEPG PepGenoption or derivative · BiotechnologySEC FORM 4 Code A—26,000 at $0.00filing
23 Jun 2022filed 24 Jun 2022Oncorusoption or derivativeSEC FORM 4 Code A—12,500 at $0.00filing
16 Jun 2021filed 17 Jun 2021Oncorusoption or derivativeSEC FORM 4 Code A—12,500 at $0.00filing
6 Oct 2020filed 8 Oct 2020Oncorusoption or derivativeSEC FORM 4 Code A—42,970 at $0.00filing
31 Jul 2019filed 25 Oct 2019Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—0filing
31 Jul 2019filed 2 Aug 2019Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—45,000 at $0.00filing
31 May 2018filed 15 Jun 2018Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—35,000 at $0.00filing
12 Jun 2017filed 14 Jun 2017Adverum BiotechnologiesSEC FORM 4 Code A—22,727 at $0.00filing
12 Jun 2017filed 14 Jun 2017Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—33,602 at $0.00filing
11 May 2016filed 1 Jul 2016Adverum BiotechnologiesSEC FORM 4 Code A—24,155 at $0.00filing
11 May 2016filed 1 Jul 2016Adverum Biotechnologiesoption or derivativeSEC FORM 4 Code A—44,248 at $0.00filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Code M$367K15,000 at $24.47filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$913K4,842 at $188.59filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$301K1,593 at $189.25filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$592K3,106 at $190.57filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$770K4,022 at $191.42filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$156K813 at $192.36filing
1 Jun 2015filed 3 Jun 2015bluebird bioSEC FORM 4 Sold$72K375 at $193.31filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed16

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.